Annual Interest Expense
$2.14 M
+$358.00 K+20.04%
31 December 2023
Summary:
BioLineRx annual interest expense is currently $2.14 million, with the most recent change of +$358.00 thousand (+20.04%) on 31 December 2023. During the last 3 years, it has risen by +$674.00 thousand (+45.85%). BLRX annual interest expense is now -4.84% below its all-time high of $2.25 million, reached on 31 December 2019.BLRX Interest Expense Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Interest Expense
$1.63 M
-$460.00 K-22.06%
30 September 2024
Summary:
BioLineRx quarterly interest expense is currently $1.63 million, with the most recent change of -$460.00 thousand (-22.06%) on 30 September 2024. Over the past year, it has increased by +$788.00 thousand (+94.15%). BLRX quarterly interest expense is now -22.06% below its all-time high of $2.08 million, reached on 30 June 2024.BLRX Quarterly Interest Expense Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM Interest Expense
$3.68 M
+$788.00 K+27.23%
30 September 2024
Summary:
BioLineRx TTM interest expense is currently $3.68 million, with the most recent change of +$788.00 thousand (+27.23%) on 30 September 2024. Over the past year, it has dropped by -$373.00 thousand (-9.20%). BLRX TTM interest expense is now -9.20% below its all-time high of $4.05 million, reached on 30 September 2023.BLRX TTM Interest Expense Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
BLRX Interest Expense Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +20.0% | +94.2% | -9.2% |
| 3 y3 years | +45.9% | +522.6% | +217.4% |
| 5 y5 years | +639.3% | +172.2% | +126.2% |
BLRX Interest Expense High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | at high | +117.9% | -22.1% | +269.8% | -9.2% | +322.7% |
| 5 y | 5 years | -4.8% | +639.3% | -22.1% | +269.8% | -9.2% | +322.7% |
| alltime | all time | -4.8% | -22.1% | +269.8% | -9.2% |
BioLineRx Interest Expense History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $1.63 M(-22.1%) | $3.68 M(+27.2%) |
| June 2024 | - | $2.08 M(+124.4%) | $2.89 M(+34.9%) |
| Mar 2024 | - | $929.00 K(-197.1%) | $2.15 M(+0.1%) |
| Dec 2023 | $2.14 M(+20.0%) | -$957.00 K(-214.3%) | $2.14 M(-47.1%) |
| Sept 2023 | - | $837.00 K(-37.4%) | $4.05 M(+16.4%) |
| June 2023 | - | $1.34 M(+44.2%) | $3.48 M(+37.9%) |
| Mar 2023 | - | $927.00 K(-2.8%) | $2.53 M(+41.5%) |
| Dec 2022 | $1.79 M(+81.5%) | $954.00 K(+257.3%) | $1.79 M(+76.1%) |
| Sept 2022 | - | $267.00 K(-29.6%) | $1.01 M(+0.6%) |
| June 2022 | - | $379.00 K(+103.8%) | $1.01 M(+15.7%) |
| Mar 2022 | - | $186.00 K(+2.2%) | $871.00 K(-11.5%) |
| Dec 2021 | $984.00 K(-33.1%) | $182.00 K(-30.3%) | $984.00 K(-15.2%) |
| Sept 2021 | - | $261.00 K(+7.9%) | $1.16 M(-3.4%) |
| June 2021 | - | $242.00 K(-19.1%) | $1.20 M(-11.4%) |
| Mar 2021 | - | $299.00 K(-16.5%) | $1.35 M(-7.8%) |
| Dec 2020 | $1.47 M(-34.8%) | $358.00 K(+18.5%) | $1.47 M(-21.9%) |
| Sept 2020 | - | $302.00 K(-23.7%) | $1.88 M(-13.6%) |
| June 2020 | - | $396.00 K(-4.3%) | $2.18 M(-2.0%) |
| Mar 2020 | - | $414.00 K(-46.2%) | $2.22 M(-1.5%) |
| Dec 2019 | $2.25 M(+676.9%) | $769.00 K(+28.8%) | $2.25 M(+38.4%) |
| Sept 2019 | - | $597.00 K(+35.7%) | $1.63 M(+56.2%) |
| June 2019 | - | $440.00 K(-1.6%) | $1.04 M(+70.0%) |
| Mar 2019 | - | $447.00 K(+210.4%) | $613.00 K(+64.8%) |
| Dec 2018 | $290.00 K | $144.00 K(+1209.1%) | $372.00 K(+74.6%) |
| Sept 2018 | - | $11.00 K(0.0%) | $213.00 K(+2.4%) |
| June 2018 | - | $11.00 K(-94.7%) | $208.00 K(+4.0%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2018 | - | $206.00 K(-1473.3%) | $200.00 K(>+9900.0%) |
| Dec 2017 | $0.00 | -$15.00 K(-350.0%) | $0.00(-100.0%) |
| Sept 2017 | - | $6000.00(+100.0%) | $15.00 K(+15.4%) |
| June 2017 | - | $3000.00(-50.0%) | $13.00 K(-13.3%) |
| Mar 2017 | - | $6000.00(+50.0%) | $15.00 K(+15.4%) |
| Sept 2016 | - | $4000.00(-20.0%) | $13.00 K(-87.0%) |
| June 2016 | - | $5000.00(+25.0%) | $100.00 K(+3.1%) |
| Mar 2016 | - | $4000.00(-95.6%) | $97.00 K(-11.8%) |
| Sept 2015 | - | $91.00 K(+4450.0%) | $110.00 K(+478.9%) |
| June 2015 | - | $2000.00(-88.2%) | $19.00 K(-95.8%) |
| Mar 2015 | - | $17.00 K(>+9900.0%) | $452.00 K(-12.4%) |
| Sept 2014 | - | $0.00(-100.0%) | $516.00 K(-51.5%) |
| June 2014 | - | $435.00 K(+437.0%) | $1.06 M(-3.1%) |
| Mar 2014 | - | $81.00 K(-85.2%) | $1.10 M(-30.2%) |
| Sept 2013 | - | $548.20 K(+16.7%) | $1.57 M(+9.0%) |
| June 2013 | - | $469.60 K(-15.4%) | $1.44 M(+41.8%) |
| Mar 2013 | - | $555.30 K(+32.7%) | $1.02 M(-4.3%) |
| Sept 2012 | - | $418.60 K(+851.4%) | $1.06 M(+63.7%) |
| June 2012 | - | $44.00 K(-92.7%) | $649.40 K(-44.9%) |
| Mar 2012 | - | $600.60 K(>+9900.0%) | $1.18 M(-13.8%) |
| Sept 2011 | - | $4800.00(-99.2%) | $1.37 M(-43.5%) |
| June 2011 | - | $573.90 K(-27.4%) | $2.42 M(+30.6%) |
| Mar 2011 | - | $790.10 K(-25.3%) | $1.85 M(+38.0%) |
| Sept 2010 | - | $1.06 M(>+9900.0%) | $1.34 M(+369.7%) |
| June 2010 | - | $6200.00(-97.8%) | $285.90 K(+2.2%) |
| Mar 2010 | - | $279.70 K | $279.70 K |
FAQ
- What is BioLineRx annual interest expense?
- What is the all time high annual interest expense for BioLineRx?
- What is BioLineRx annual interest expense year-on-year change?
- What is BioLineRx quarterly interest expense?
- What is the all time high quarterly interest expense for BioLineRx?
- What is BioLineRx quarterly interest expense year-on-year change?
- What is BioLineRx TTM interest expense?
- What is the all time high TTM interest expense for BioLineRx?
- What is BioLineRx TTM interest expense year-on-year change?
What is BioLineRx annual interest expense?
The current annual interest expense of BLRX is $2.14 M
What is the all time high annual interest expense for BioLineRx?
BioLineRx all-time high annual interest expense is $2.25 M
What is BioLineRx annual interest expense year-on-year change?
Over the past year, BLRX annual interest expense has changed by +$358.00 K (+20.04%)
What is BioLineRx quarterly interest expense?
The current quarterly interest expense of BLRX is $1.63 M
What is the all time high quarterly interest expense for BioLineRx?
BioLineRx all-time high quarterly interest expense is $2.08 M
What is BioLineRx quarterly interest expense year-on-year change?
Over the past year, BLRX quarterly interest expense has changed by +$788.00 K (+94.15%)
What is BioLineRx TTM interest expense?
The current TTM interest expense of BLRX is $3.68 M
What is the all time high TTM interest expense for BioLineRx?
BioLineRx all-time high TTM interest expense is $4.05 M
What is BioLineRx TTM interest expense year-on-year change?
Over the past year, BLRX TTM interest expense has changed by -$373.00 K (-9.20%)